diclofenac has been researched along with aminolevulinic acid in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Alam, M; Goldberg, LH; Silapunt, S | 1 |
| Jorizzo, JL | 1 |
| Gold, MH | 1 |
| Krekels, GA; Van der Geer, S | 1 |
| Chimenti, S; Colombo, GL; Di Matteo, S; Fargnoli, MC; Frascione, P; Peris, K; Silipo, V | 1 |
| Goldenberg, G; Skupsky, H; Skupsky, J | 1 |
| Gupta, AK; Paquet, M | 1 |
| Calzavara-Pinton, PG; Facchinetti, E; Rossi, MT; Specchia, C; Zane, C | 1 |
| Calzavara-Pinton, P; Pacou, M; Szeimies, RM; Zane, C | 1 |
| Gaber, B; Koch, A; Wollina, U | 1 |
| Bottoniτ, U; Calvieri, S; Cantisani, C; Cantoresi, F; Didona, D; Losco, L; Mercuri, SR; Moliterni, E; Paolino, G; Scarnò, M; Tallarico, M | 1 |
| Calzavara-Pinton, P; Hamon, P; Tanova, N | 1 |
| Cornacchia, L; Lai, M; Longo, C; Pampena, R; Pellacani, G; Peris, K | 1 |
| Arisi, M; Calzavara-Pinton, I; Calzavara-Pinton, PG; Caravello, S; Cozzi, C; Moggio, E; Polonioli, M; Rossi, MT; Soglia, S; Tomasi, C; Venturini, M; Zane, C | 1 |
| Arcuri, D; Iannattone, L; Lagacé, F; Lefrançois, P; Litvinov, IV; Netchiporouk, E; Ramchatesingh, B | 1 |
| Andersen, F; Bjerring, P; Haedersdal, M; Lerche, CM; Pihl, C | 1 |
9 review(s) available for diclofenac and aminolevulinic acid
| Article | Year |
|---|---|
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
Topical and light-based treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclooxygenase Inhibitors; Diclofenac; Fluorouracil; Humans; Hyaluronic Acid; Imiquimod; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Precancerous Conditions; Retinoids; Skin Neoplasms; Vitamin A | 2003 |
Current and novel treatment options for actinic keratosis.
Topics: Aminolevulinic Acid; Aminoquinolines; Cryotherapy; Diclofenac; Fluorouracil; Gels; Humans; Imiquimod; Immunosuppressive Agents; Keratosis; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2004 |
Disseminated superficial actinic porokeratosis: a treatment review.
Topics: Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cholecalciferol; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Laser Therapy; Photochemotherapy; Photosensitizing Agents; Porokeratosis; Retinoids; Vitamins | 2012 |
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cryotherapy; Diclofenac; Diterpenes; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Hyaluronic Acid; Imiquimod; Immunocompetence; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
Topics: Adjuvants, Immunologic; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Photochemotherapy; Randomized Controlled Trials as Topic; Sunlight | 2016 |
Treatments of actinic cheilitis: A systematic review of the literature.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Dermabrasion; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Photochemotherapy; Precancerous Conditions; Treatment Outcome | 2020 |
Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review.
Topics: Aminolevulinic Acid; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2023 |
Improving the efficacy of photodynamic therapy for actinic keratosis: A comprehensive review of pharmacological pretreatment strategies.
Topics: Aminolevulinic Acid; Diclofenac; Fluorouracil; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Retinoids; Salicylic Acid; Treatment Outcome; Urea; Vitamin D | 2023 |
5 trial(s) available for diclofenac and aminolevulinic acid
| Article | Year |
|---|---|
Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Double-Blind Method; Female; Gels; Hand Dermatoses; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Treatment Outcome | 2009 |
A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cost-Benefit Analysis; Diclofenac; Drug Combinations; Facial Dermatoses; Female; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses; Treatment Outcome | 2014 |
PHOTODYNAMIC TREATMENT WITH NANOEMULSIFIED 5-AMINOLEVULINIC ACID AND NARROW BAND RED LIGHT FOR FIELD CANCERIZATION DUE TO OCCUPATIONAL EXPOSURE TO ULTRAVIOLET LIGHT IRRADIATION.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Diclofenac; Emulsions; Female; Humans; Keratosis, Actinic; Male; Nanostructures; Occupational Exposure; Pain Management; Pain Measurement; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays; Welding | 2018 |
Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Quality of Life; Rome; Severity of Illness Index; Skin; Time Factors; Treatment Outcome | 2018 |
Effects of MAL-PDT, ingenol mebutate and diclofenac plus hyaluronate gel monitored by high-frequency ultrasound and digital dermoscopy in actinic keratosis - a randomized trial.
Topics: Aminolevulinic Acid; Dermoscopy; Diclofenac; Diterpenes; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2020 |
5 other study(ies) available for diclofenac and aminolevulinic acid
| Article | Year |
|---|---|
New treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Cryosurgery; Diclofenac; Gels; Imiquimod; Ointments; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents | 2002 |
New treatments for actinic keratoses.
Topics: Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Dermatologic Agents; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Sunscreening Agents; United States | 2002 |
Pharmacoeconomic analysis of the treatment of multiple actinic keratoses.
Topics: Aminolevulinic Acid; Aminoquinolines; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cryotherapy; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Treatment Outcome | 2008 |
Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system.
Topics: Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Cost-Benefit Analysis; Decision Trees; Delivery of Health Care; Diclofenac; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic | 2010 |
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |